ALFA Finder| Revenue growth | 13.7% YoY increase in Total Income. |
|---|---|
| Margins | EBITDA margin at 36.4%; PAT margin at 18.6%. |
| Demand visibility | High demand for drug discovery and electronics testing services. |
Growth
Revenue hit ₹1,129 Mn (up 13.7% YoY). PAT grew 11.4% YoY to ₹210 Mn.
Outlook
Invested ₹180 Mn in CAPEX during Q1; historical 4-year revenue CAGR stands at 10.5%.
Risks
Economic volatility, currency fluctuations, and increasing competition in the CRTO industry.
Last quarter's promises, checked
Delivered
- Guided 35% EBITDA margin → delivered 36.4% (= BEAT)
- Targeted double-digit revenue growth → delivered 13.7% (= BEAT)
- Maintain net debt-free status → delivered 0.01 D/E (= BEAT)
Partly delivered
- Commence Biologics services in FY27 → Started with ₹180 Mn CAPEX/infrastructure (= PARTIAL)
Missed
- Targeted ₹500 Cr annualized run rate by Q4 FY26 → delivered ₹416.3 Cr (= MISS)
Earnings Call filed with BSE, NSE: VIMTALABS. Summary written with AI assistance from the document.
Vimta Labs Ltd: key numbers
- Share price
- ₹513.15
- Market cap
- ₹2,294 Cr
- Revenue (annual)
- ₹407.3 Cr
- Net profit (annual)
- ₹77.51 Cr
- P/E (TTM)
- 28.6×Sector 54.5×
- Promoter holding
- 35.64%-0.03% QoQ
- FII holding
- 5.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vimta Labs Ltd
All →Vimta Labs Merger & Restructuring Worth ₹0.08 Cr
Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.
- Value
- ₹0.08 Cr
Vimta Labs Earnings Call Transcript: Key Takeaways
Stable Q2 performance masked by R&D lulls and logistics headwinds.
- Call
- Guides 25% growth
Vimta Labs Results Update
Vimta Labs reported Q2 FY27 income of ₹1,149 Mn, up 9.9% YoY, and PAT of ₹206 Mn at 17.9% margin. EBITDA margins held steady at 35.5%.
Vimta Labs Investor Presentation: Key Takeaways
Q2 FY27: total income Rs1,149Mn (+9.9% YoY), EBITDA Rs408Mn (35.5% margin), PAT Rs206Mn (17.9% margin, +3.5% YoY). H1 FY27 PAT Rs417Mn (+7.3%).
Vimta Labs Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 3.5% YoY
Vimta Labs Ltd reported revenue from operations of ₹112 Cr (+10.0% YoY) and net profit of ₹20.6 Cr (+3.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.6 Cr · +3.5% YoY
Vimta Labs Board Meeting Date
Vimta Labs will hold a board meeting on 30 October 2026 to consider half-year results. Trading window stays closed from 01 October.